ICG-001
β-catenin inhibitor
Product Specifications
Background
Inhibitor of TCF/β-catenin-mediated transcription. Selectively inhibits β-catenin/CBP interaction; displays no effect on β-catenin/p300 interaction. Exhibits growth inhibitory effects in colon carcinoma cell lines (SW480 and HCT-116 cells); also displays efficacy in Min mouse and nude mouse SW620 xenograft models.
Product Name Alternative
(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
UNSPSC
41116105
Source
Synthetic
Purity
>98%
Weight
0.005
Format
White solid
Solubility
Soluble to 100 mM in DMSO and to 50 mM in ethanol
Molecular Formula
C33H32N4O4
Molecular Weight
548.63
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Emami K.H., et al. (2004) Proc. Natl. Acad. Sci. USA. 101(34): 12682-7.
2. De Sousa E.M., et al. (2011) Clin. Cancer Res. 17(4): 647-53.
3. Zhou B., et al. (2012) J. Biol. Chem. 287(10): 7026-38.
CAS Number
847591-62-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6190958-01 0.1 mL
LHX3 (LIM/Homeobox Protein Lhx3, LIM Homeobox Protein 3, DKFZp762A2013) (MaxLight 405)
Ask
View Details MBS6190958-02 5x 0.1 mL
LHX3 (LIM/Homeobox Protein Lhx3, LIM Homeobox Protein 3, DKFZp762A2013) (MaxLight 405)
Ask
View Details 
MBS1451172-01 0.02 mg (E-Coli)
Recombinant Helicobacter acinonychis Glucokinase (glk)
Ask
View Details 
MBS1451172-02 0.02 mg (Yeast)
Recombinant Helicobacter acinonychis Glucokinase (glk)
Ask
View Details MBS1451172-03 0.1 mg (E-Coli)
Recombinant Helicobacter acinonychis Glucokinase (glk)
Ask
View Details MBS1451172-04 0.1 mg (Yeast)
Recombinant Helicobacter acinonychis Glucokinase (glk)
Ask
View Details